Cromwell Holdings LLC Sells 172 Shares of Humana Inc. $HUM

Cromwell Holdings LLC trimmed its stake in Humana Inc. (NYSE:HUM) by 58.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 120 shares of the insurance provider’s stock after selling 172 shares during the period. Cromwell Holdings LLC’s holdings in Humana were worth $29,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Vanguard Group Inc. grew its position in Humana by 8.9% during the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock worth $3,697,222,000 after buying an additional 1,143,662 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Humana by 3,257.5% in the 1st quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider’s stock worth $307,624,000 after acquiring an additional 1,127,973 shares during the period. Nuveen LLC acquired a new stake in shares of Humana during the 1st quarter worth approximately $171,220,000. Dodge & Cox increased its position in shares of Humana by 5.5% during the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock valued at $2,845,830,000 after purchasing an additional 557,175 shares during the period. Finally, Pzena Investment Management LLC increased its position in shares of Humana by 6.1% during the first quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider’s stock valued at $1,013,133,000 after purchasing an additional 219,541 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on HUM shares. Barclays decreased their price target on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating on the stock in a research note on Friday. Sanford C. Bernstein upped their target price on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Evercore ISI began coverage on Humana in a research note on Monday, September 22nd. They issued an “in-line” rating and a $295.00 price objective on the stock. Mizuho set a $300.00 target price on Humana in a research report on Friday. Finally, Robert W. Baird dropped their price objective on Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a research note on Friday, July 25th. Seven investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Humana currently has an average rating of “Hold” and an average target price of $291.21.

Humana Price Performance

Shares of HUM stock opened at $284.00 on Friday. The stock’s fifty day moving average is $274.76 and its 200-day moving average is $257.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The stock has a market capitalization of $34.16 billion, a PE ratio of 21.80, a PEG ratio of 1.51 and a beta of 0.42.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana’s dividend payout ratio is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.